Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Calcitonin (CT) is a known inhibitor of bone resorption. Calcitonin gene-related peptide-alpha (CGRPalpha), produced by alternative RNA processing of the CT/CGRP gene, has no clearly defined role in bone. To better understand the physiologic role of the CT/CGRP gene we created a mouse in which the coding sequences for both CT and CGRPalpha were deleted by homologous recombination. The CT/CGRP(-/-) knockout (KO) mice procreated normally, there were no identifiable developmental defects at birth, and they had normal baseline calcium-related chemistry values. However, KO animals were more responsive to exogenous human parathyroid hormone as evidenced by a greater increase of the serum calcium concentration and urine deoxypyridinoline crosslinks, an effect reversed by CT and mediated by a greater increase in bone resorption than in controls. Surprisingly, KO mice have significantly greater trabecular bone volume and a 1.5- to 2-fold increase in bone formation at 1 and 3 months of age. This effect appears to be mediated by increased bone formation. In addition, KO mice maintain bone mass following ovariectomy, whereas wild-type mice lose approximately one-third of their bone mass over 2 months. These findings argue for dual roles for CT/CGRP gene products: prevention of bone resorption in hypercalcemic states and a regulatory role in bone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The phenotype of the Calca KO mice suggested that the osteoblast is the primary target of calcitonin/CGRP in bone and that calcitonin/CGRP inhibit bone formation.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The mice had no developmental defects and had normal baseline-circulating calcium levels.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“However, as the mice were deficient in both calcitonin and ␣CGRP, it was unclear which of the two peptides was responsible for the phenotype (97).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“Calca KO mice were less sensitive to OVX, maintaining their bone mass, whereas WT mice lost one-third of bone mass over 2 mo after OVX.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“Surprisingly, the Calca KO mice had significantly greater trabecular bone volume resulting from increased bone formation.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140 · cited 1×
“The immunoperoxidase analysis was performed on formalinfixed, paraffin-embedded tissues using the avidin-biotinperoxidase complex method (33).”
MethodParfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“A reinterpretation of these data based on the elucidation of the CGRPα/ RAMP receptor system (53, 54) suggests that CGRP at high concentrations cross-reacts with the CT receptor.”
MethodAmara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Evidence for Calcitonin—A New Hormone from the Parathyroid That Lowers Blood Calcium
COPP, D. H., CAMERON, E. C., CHENEY, B. A., DAVIDSON, A. G. F., & HENZE, K. G. (1962) · Endocrinology · doi:10.1210/endo-70-5-638 · Cited by 697 · cited 1×
“This substance was named calcitonin (CT) because it was presumed to play a role in regulating calcium metabolism (2).”
BackgroundAmling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J. M., Baron, R., & Demay, M. B. (1999) · Endocrinology · doi:10.1210/endo.140.11.7110 · Cited by 499
Self-citationNicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 1×
“Since the discovery of CT, multiple studies have confirmed its hypocalcemic effect, which is mediated by the interaction of CT with a specific receptor on the osteoclast (10, 11).”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451 · cited 1×
“Since the discovery of CT, multiple studies have confirmed its hypocalcemic effect, which is mediated by the interaction of CT with a specific receptor on the osteoclast (10, 11).”
Background
Research works printed but not linked: 5
- Copp, 1961, Proc. Canad. Fed. Biol. Soc., 4, 17
- Singer, 1977, Clin. Orthop., 127, 86
- Becker, 1980, Arch. Pathol. Lab. Med., 104, 196
- Marie, 2000, Joint Bone Spine., 67, 150
- Tilakaratne, 2000, J. Pharmacol. Exp. Ther., 294, 61
Cited by
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
“This is because its deletion yields a high bone mass rather than an osteopenic phenotyp”
BackgroundCalcium Absorption Across Epithelia
Hoenderop, J. G. J., Nilius, B., & Bindels, R. J. M. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2004 · Cited by 936
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
“macrophage line, so the ability of CGRP to inhibit bone resorption/stimulate bone formation is probably related to a direct action on osteoclasts (149, 285).”
BackgroundOsteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Becker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Metadata
- Authors
- Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., Amling, M., & Gagel, R. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Universität Hamburg (DE)
- Baylor College of Medicine (US)
- Corresponding author
- Gagel, Robert F.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-15
- Volume
- 110
- Issue
- 12
- Pages
- 1849-1857
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC151647
- OpenAlex
- W2160364738
- Cited by
- 209
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 10 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 6
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk046660-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-46660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- calcitonin, calcitonin gene-related peptide, bone mass, bone resorption, bone formation, trabecular bone volume, parathyroid hormone response, hypercalcemia, ovariectomy, bone loss, deoxypyridinoline, calcium homeostasis
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Calcitonin, Estrogens, Female, Humans, Male, Mice, Inbred C57BL, Osteoclasts, Osteogenesis, Ovariectomy, Parathyroid Hormone, Phenotype, Radiography, Thyroid Gland, Bone Density, Calcitonin Gene-Related Peptide, Gene Deletion, Alternative Splicing, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. https://app.cochat.ai/papers/10.1172/jci200214218
- The paper
- Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., Amling, M., & Gagel, R. F. (2002). Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. Journal of Clinical Investigation. https://doi.org/10.1172/jci200214218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.